Mastoparan-L [A5I, A8R]

General Information


DRACP ID  DRACP03644

Peptide Name   Mastoparan-L [A5I, A8R]

Sequence  INLKILARLAKKIL

Sequence Length  14

UniProt ID  P01514 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C76H143N21O16

Absent amino acids  CDEFGHMPQSTVWY

Common amino acids  L

Mass  183919

Pl  11.92

Basic residues  4

Acidic residues  0

Hydrophobic residues  9

Net charge  4

Boman Index  -15

Hydrophobicity  90

Aliphatic Index  209.29

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 27423268

Title  Selective amino acid substitution reduces cytotoxicity of the antimicrobial peptide mastoparan

Doi Not available

Year  2016

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  9494

DRACP is developed by Dr.Zheng's team.